Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · see citing works

Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria

Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works

Primary Progressive Aphasia

Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,012 · see citing works

The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes

Appelhof, B., Bakker, C., den IJssel, J. C. L. V. D., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,773 · see citing works

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

Rissin, D. M., Kan, C. W., Campbell, T. G., Howes, S. C., Fournier, D. R., Song, L., Piech, T., Patel, P. P., Chang, L., Rivnak, A. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1641 · Cited by 2,119 · see citing works

What are biomarkers?

Strimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062 · see citing works

Neurofilaments as biomarkers in neurological disorders

Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988 · see citing works

Biomarker definitions and their applications

Califf, R. M. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217750088 · Cited by 1,546 · see citing works

Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis

Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164 · see citing works

A Structural Scaffolding of Intermediate Filaments in Health and Disease

Fuchs, E. V., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,013 · see citing works

The diagnosis of Parkinson’s disease

Tolosa, E., Wenning, G., & Poewe, W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70285-4 · Cited by 902 · see citing works

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740 · see citing works

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688 · see citing works

Multiple sclerosis: a two-stage disease

Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 660 · see citing works

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563 · see citing works

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease

Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 525 · see citing works

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Barro, C., Benkert, P., Disanto, G., Tsagkas, C., Amann, M., Naegelin, Y., Leppert, D., Gobbi, C., Granziera, C., Yaldizli, Ö., et al. (2018) · Brain · doi:10.1093/brain/awy154 · Cited by 517 · see citing works

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

Hansson, O., Janelidze, S., Hall, S., Magdalinou, N., Lees, A. J., Andreasson, U., Norgren, N., Linder, J., Forsgren, L., Constantinescu, R., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003680 · Cited by 506 · see citing works

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499 · see citing works

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

Zetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487 · see citing works

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Gaiottino, J., Norgren, N., Dobson, R., Topping, J. H., Nissim, A., Malaspina, A., Bestwick, J. P., Monsch, A. U., Regeniter, A., Lindberg, R. L. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075091 · Cited by 486 · see citing works

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Gisslén, M., Price, R. W., Andreasson, U., Norgren, N., Nilsson, S., Hagberg, L., Fuchs, D., Spudich, S., Blennow, K., & Zetterberg, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.036 · Cited by 481 · see citing works

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

Hall, S., Öhrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., Widner, H., Decraemer, H., Nägga, K., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1654 · Cited by 473 · see citing works

Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes—What Do We Know?

Winklewski, P. J., Sabisz, A., Naumczyk, P., Jodzio, K., Szurowska, E., & Szarmach, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00092 · Cited by 463 · see citing works

Biomarkers in amyotrophic lateral sclerosis

Turner, M. R., Kiernan, M. C., Leigh, P. N., & Talbot, K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70293-x · Cited by 440 · see citing works

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

Rohrer, J. D., Woollacott, I., Dick, K. M., Brotherhood, E., Gordón, E., Fellows, A. D., Toombs, J., Druyeh, R., Cardoso, M. J., Sebastien Ourselin, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003154 · Cited by 431 · see citing works

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Novakova, L., Zetterberg, H., Sundström, P., Axelsson, M., Khademi, M., Gunnarsson, M., Malmeström, C., Svenningsson, A., Olsson, T., Piehl, F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004683 · Cited by 426 · see citing works

Biomarkers of Parkinson’s disease: Present and future

Miller, D. B., & O'Callaghan, J. P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.030 · Cited by 403 · see citing works

The neurobiological basis of cognitive impairment in Parkinson's disease

Halliday, G. M., Leverenz, J. B., Schneider, J. S., & Adler, C. H. (2014) · Movement Disorders · doi:10.1002/mds.25857 · Cited by 366 · see citing works

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Byrne, L. M., Rodrigues, F. B., Blennow, K., Durr, A., Leavitt, B. R., Roos, R. A. C., Scahill, R. I., Tabrizi, S. J., Zetterberg, H., Langbehn, D., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30124-2 · Cited by 364 · see citing works

White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI

Zhang, Y., Schuff, N., Du, A.-T., Rosen, H. J., Kramer, J. H., Gorno-Tempini, M. L., Miller, B. L., & Weiner, M. W. (2009) · Brain · doi:10.1093/brain/awp071 · Cited by 356 · see citing works

Is increased blinking a form of blepharospasm?

(2013) · CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) · doi:10.1212/wnl · Cited by 355 · see citing works

Elevated neurofilament levels in neurological diseases

Norgren, N., Rosengren, L., & Stigbrand, T. I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03219-0 · Cited by 351 · see citing works

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Gunnarsson, M., Malmeström, C., Axelsson, M., Sundström, P., Dahle, C., Vrethem, M., Olsson, T. P., Piehl, F., Norgren, N., Rosengren, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22247 · Cited by 346 · see citing works

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Shahim, P., Gren, M., Liman, V., Andreasson, U., Norgren, N., Tegner, Y., Mattsson, N., Andreasen, N., Öst, M., Zetterberg, H., et al. (2016) · Scientific Reports · doi:10.1038/srep36791 · Cited by 336 · see citing works

Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports

Shahim, P., Zetterberg, H., Tegner, Y., & Blennow, K. (2017) · Neurology · doi:10.1212/wnl.0000000000003912 · Cited by 332 · see citing works

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318 · see citing works

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Steinacker, P., Feneberg, E., Weishaupt, J. H., Brettschneider, J., Tumani, H., Andersen, P. M., Arnim, C. A. F. V., Böhm, S., Kassubek, J., Kubisch, C., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311387 · Cited by 316 · see citing works

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis

Lycke, J., Karlsson, J.-E., Andersen, O., & Rosengren, L. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.402 · Cited by 315 · see citing works

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Lewczuk, P., Ermann, N., Andréasson, U., Schultheis, C., Podhorná, J., Spitzer, P., Maler, J. M., Kornhuber, J., Blennow, K., & Zetterberg, H. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0404-9 · Cited by 307 · see citing works

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

Comabella, M., Fernández, M., Martinꝉ, R., Rivera-Vallvé, S., Borràs, E., Chiva, C., Julià, E., Rovira, À., Cantó, E., Alvarez-Cermeño, J. C., et al. (2010) · Brain · doi:10.1093/brain/awq035 · Cited by 302 · see citing works

Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease

Jordanova, A. (2003) · Brain · doi:10.1093/brain/awg059 · Cited by 302 · see citing works

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Mattsson, N., Insel, P. S., Palmqvist, S., Portelius, E., Zetterberg, H., Weiner, M. W., Blennow, K., Hansson, O., & Initiative, T. A. D. N. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606540 · Cited by 293 · see citing works

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Verde, F., Steinacker, P., Weishaupt, J. H., Kassubek, J., Oeckl, P., Halbgebauer, S., Tumani, H., Arnim, C. A. F. V., Dorst, J., Feneberg, E., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318704 · Cited by 271 · see citing works

Extrasynaptic volume transmission and diffusion parameters of the extracellular space

Syková, E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.077 · Cited by 265 · see citing works

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263 · see citing works

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263 · see citing works

Genetics and Neuropathology of Huntington's Disease

Reiner, A. J., Dragatsis, I., & Dietrich, P. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00014-6 · Cited by 262 · see citing works

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

Kuhle, J., Barro, C., Disanto, G., Mathias, A., Soneson, C., Bonnier, G., Yaldizli, Ö., Regeniter, A., Derfuss, T., Canales, M., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515623365 · Cited by 257 · see citing works

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

Lin, Y.-S., Lee, W.-J., Wang, S.-J., & Fuh, J.-L. (2018) · Scientific Reports · doi:10.1038/s41598-018-35766-w · Cited by 251 · see citing works

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

Scherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., Kramer, J. H., Rabinovici, G., Ahlijanian, M., Miller, B. L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24052 · Cited by 249 · see citing works

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration

Weston, P. S. J., Poole, T., Ryan, N. S., Nair, A., Liang, Y., Macpherson, K., Druyeh, R., Malone, I. B., Ahsan, R. L., Pemberton, H., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004667 · Cited by 245 · see citing works

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease

Poesen, K., Schaepdryver, M. D., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004029 · Cited by 237 · see citing works

Plasma neurofilament light chain concentration in the inherited peripheral neuropathies

Sandelius, Å., Zetterberg, H., Blennow, K., Adiutori, R., Malaspina, A., Laurá, M., Reilly, M. M., & Rossor, A. M. (2018) · Neurology · doi:10.1212/wnl.0000000000004932 · Cited by 237 · see citing works

Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success

Timmerman, V., Strickland, A. V., & Züchner, S. (2014) · Genes · doi:10.3390/genes5010013 · Cited by 234 · see citing works

Neurofilaments as biomarkers in multiple sclerosis

Teunissen, C. E., & Khalil, M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512443092 · Cited by 234 · see citing works

Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis

Carson, M. J. (2002) · Glia · doi:10.1002/glia.10145 · Cited by 227 · see citing works

Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?

Williams, A., Piaton, G., Aigrot, M., Belhadi, A., Théaudin, M., Petermann, F., Thomas, J., Zalc, B., & Lubetzki, C. (2007) · Brain · doi:10.1093/brain/awm202 · Cited by 227 · see citing works

Serum neurofilament light

Tiedt, S., Duering, M., Barro, C., Kaya, A. G., Boeck, J., Bode, F. J., Klein, M., Dorn, F., Gesierich, B. G., Kellert, L., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006282 · Cited by 224 · see citing works

Neuronal Aggregates: Formation, Clearance, and Spreading

Lim, J., & Yue, Z. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.02.002 · Cited by 221 · see citing works

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis

Weydt, P., Oeckl, P., Huss, A. M., Müller, K., Volk, A. E., Kühle, J., Knehr, A., Andersen, P. M., Prudlo, J., Steinacker, P., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24552 · Cited by 217 · see citing works

Huntington disease models and human neuropathology: similarities and differences

Vonsattel, J. P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0306-6 · Cited by 210 · see citing works

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

Siller, N., Kühle, J., Muthuraman, M., Barro, C., Uphaus, T., Groppa, S., Kappos, L., Zipp, F., & Bittner, S. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518765666 · Cited by 205 · see citing works

White-matter integrity on DTI and the pathologic staging of Alzheimer’s disease

Kantarci, K., Murray, M. E., Schwarz, C. G., Reid, R. I., Przybelski, S. A., Lesnick, T., Zuk, S. M., Raman, M. R., Senjem, M. L., Gunter, J. L., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.024 · Cited by 205 · see citing works

Serum neurofilament is associated with progression of brain atrophy and disability in early MS

Kühle, J., Nourbakhsh, B., Grant, D., Morant, S. V., Barro, C., Yaldizli, Ö., Pelletier, D., Giovannoni, G., Waubant, E. L., & Gnanapavan, S. (2017) · Neurology · doi:10.1212/wnl.0000000000003653 · Cited by 203 · see citing works

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

Feneberg, E., Oeckl, P., Steinacker, P., Verde, F., Barro, C., Damme, P. V., Gray, E., Großkreutz, J., Jardel, C., Kühle, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004761 · Cited by 203 · see citing works

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

Kühle, J., Gaiottino, J., Leppert, D., Petzold, A., Bestwick, J., Malaspina, A., Lu, C., Dobson, R., Disanto, G., Norgren, N., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307454 · Cited by 197 · see citing works

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

Gaiani, A., Martinelli, I., Bello, L., Querin, G., Puthenparampil, M., Ruggero, S., Toffanin, E., Cagnin, A., Briani, C., Pegoraro, E., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5398 · Cited by 196 · see citing works

Differential diagnosis of neurodegenerative diseases using structural MRI data

Koikkalainen, J., Rhodius-Meester, H., Tolonen, A., Barkhof, F., Tijms, B., Lemstra, A. W., Tong, T., Guerrero, R., Schuh, A., Ledig, C., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.02.019 · Cited by 193 · see citing works

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease

Byrne, L. M., Rodrigues, F. B., Johnson, E. B., Wijeratne, P. A., Vita, E. D., Alexander, D. C., Palermo, G., Czech, C., Schobel, S., Scahill, R. I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7108 · Cited by 192 · see citing works

Serum neurofilament light is sensitive to active cerebral small vessel disease

Gattringer, T., Pinter, D., Enzinger, C., Seifert‐Held, T., Kneihsl, M., Fandler‐Höfler, S., Pichler, A., Barro, C., Gröbke, S., Voortman, M. M., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004645 · Cited by 189 · see citing works

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

Piehl, F., Kockum, I. S., Khademi, M., Blennow, K., Lycke, J., Zetterberg, H., & Olsson, T. P. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517715132 · Cited by 183 · see citing works

Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum

Lillo, P., Mioshi, E., Burrell, J. R., Kiernan, M. C., Hodges, J. R., & Hornberger, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043993 · Cited by 181 · see citing works

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181 · see citing works

White matter damage in frontotemporal lobar degeneration spectrum

Agosta, F., Scola, E., Canu, E., Marcone, A., Magnani, G., Sarro, L., Copetti, M., Caso, F., Cerami, C., Comi, G., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr288 · Cited by 180 · see citing works

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

Kühle, J., Disanto, G., Lorscheider, J., Stites, T. E., Chen, Y., Dahlke, F., Francis, G., Shrinivasan, A., Radue, E. W., Giovannoni, G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001491 · Cited by 176 · see citing works

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

Bergman, J., Dring, A. M., Zetterberg, H., Blennow, K., Norgren, N., Gilthorpe, J. D., Bergenheim, T. A., & Svenningsson, A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000271 · Cited by 166 · see citing works

A specific ELISA for measuring neurofilament heavy chain phosphoforms

Petzold, A., Keir, G., Green, A. J. E., Giovannoni, G., & Thompson, E. J. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00189-3 · Cited by 158 · see citing works

A comparative study of CSF neurofilament light and heavy chain protein in MS

Kuhle, J., Plattner, K., Bestwick, J. P., Lindberg, R. L., Ramagopalan, S. V., Norgren, N., Nissim, A., Malaspina, A., Leppert, D., Giovannoni, G., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513482374 · Cited by 155 · see citing works

Neurofilament protein levels in CSF are increased in dementia

Rosengren, L., Karlsson, J. E., Sjögren, M. J. C., Blennow, K., & Wallin, A. (1999) · Neurology · doi:10.1212/wnl.52.5.1090 · Cited by 154 · see citing works

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

Tortelli, R., Ruggieri, M., Cortese, R., D’Errico, E., Capozzo, R., Leo, A., Mastrapasqua, M., Zoccolella, S., Leante, R., Livrea, P., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03777.x · Cited by 151 · see citing works

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis

Chitnis, T., Gonzalez, C. T., Healy, B. C., Saxena, S., Rosso, M., Barro, C., Michalak, Z., Paul, A., Kivisäkk, P., Diaz‐Cruz, C., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.638 · Cited by 150 · see citing works

Homocysteine: a biomarker in neurodegenerative diseases

Herrmann, W., & Obeid, R. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.084 · Cited by 149 · see citing works

A Double-Blind Placebo-Controlled Randomized Trial of <i>Melissa officinalis</i> Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease

Burns, A., Perry, E., Holmes, C., Francis, P., Morris, J., Howes, M.-J. R., Chazot, P., Lees, G., & Ballard, C. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000324438 · Cited by 149 · see citing works

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

Silber, E., Semra, Y. K., Gregson, N. A., & Sharief, M. K. (2002) · Neurology · doi:10.1212/wnl.58.9.1372 · Cited by 143 · see citing works

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis

Novakova, L., Axelsson, M., Khademi, M., Zetterberg, H., Blennow, K., Malmeström, C., Piehl, F., Olsson, T. P., & Lycke, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13881 · Cited by 143 · see citing works

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Menke, R., Gray, E., Lu, C., Kühle, J., Talbot, K., Malaspina, A., & Turner, M. R. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.212 · Cited by 141 · see citing works

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

Disanto, G., Adiutori, R., Dobson, R., Martinelli, V., Costa, G. D., Runia, T. F., Evdoshenko, E. P., Thouvenot, É., Trojano, M., Norgren, N., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309690 · Cited by 141 · see citing works

Neurobiology of Huntington's Disease

Sharp, A. H., & Ross, C. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0002 · Cited by 138 · see citing works

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

Nimer, F. A., Thelin, E. P., Nyström, H., Dring, A. M., Svenningsson, A., Piehl, F., Nelson, D., & Bellander, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132177 · Cited by 136 · see citing works

Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype

Zetterberg, H., Jacobsson, J., Rosengren, L., Blennow, K., & Andersen, P. M. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01972.x · Cited by 134 · see citing works

Serum neurofilament light chain levels are related to small vessel disease burden

Duering, M., Konieczny, M. J., Tiedt, S., Baykara, E., Tuladhar, A. M., Leijsen, E. V., Lyrer, P., Engelter, S. T., Gesierich, B., Achmüller, M., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02565 · Cited by 132 · see citing works

CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease

Abdo, W. F., Bloem, B. R., van Geel, W. J. A., Esselink, R. A. J., & Verbeek, M. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.010 · Cited by 130 · see citing works

Clinically isolated syndromes

Masjuán, J., Alvarez-Cermeño, J. C., Barragán, N. G., Díaz-Sánchez, M., Espiño, M., Sádaba, M. C., González‐Porqué, P., Millán, J. M. S., & Villar, L. M. (2006) · Neurology · doi:10.1212/01.wnl.0000198253.35119.83 · Cited by 129 · see citing works

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

Landqvist Waldö, M., Frizell Santillo, A., Passant, U., Zetterberg, H., Rosengren, L., Nilsson, C., & Englund, E. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-54 · Cited by 127 · see citing works

Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging

Hoy, A. R., Ly, M., Carlsson, C. M., Okonkwo, O. C., Zetterberg, H., Blennow, K., Sager, M. A., Asthana, S., Johnson, S. C., Alexander, A. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173982 · Cited by 125 · see citing works

Inherited Peripheral Neuropathies

Saporta, M., & Shy, M. E. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.01.009 · Cited by 124 · see citing works

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

Meeter, L. H. H., Vijverberg, E. G., Del Campo, M., Rozemuller, A. J. M., Donker Kaat, L., de Jong, F. J., van der Flier, W. M., Teunissen, C. E., van Swieten, J. C., & Pijnenburg, Y. A. L. (2018) · Neurology · doi:10.1212/wnl.0000000000005261 · Cited by 122 · see citing works

CSF neurofilament proteins in the differential diagnosis of dementia

de Jong, D., Jansen, R. W. M. M., Pijnenburg, Y. A. L., van Geel, W. J. A., Borm, G. F., Kremer, H. P. H., & Verbeek, M. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107326 · Cited by 120 · see citing works

Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis

Gille, B., Schaepdryver, M. D., Goossens, J., Dedeene, L., Vocht, J. D., Oldoni, E., Goris, A., Bosch, L. V. D., Depreitere, B., Claeys, K. G., et al. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12511 · Cited by 120 · see citing works

Mild cognitive impairment in Parkinson's disease

Yarnall, A. J., Rochester, L., & Burn, D. J. (2013) · Age and Ageing · doi:10.1093/ageing/aft085 · Cited by 118 · see citing works

Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot–Marie–Tooth disease-linked mutations in NFL and HSPB1

Zhai, J., Lin, H., Julien, J., & Schlaepfer, W. W. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm272 · Cited by 117 · see citing works

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

Håkansson, I., Tisell, A., Cassel, P., Blennow, K., Zetterberg, H., Lundberg, P., Dahle, C., Vrethem, M., & Ernerudh, J. (2017) · European Journal of Neurology · doi:10.1111/ene.13274 · Cited by 117 · see citing works

Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome

Battista, A. P. D., Buonora, J., Rhind, S., Hutchison, M., Baker, A., Rizoli, S., Diaz-Arrastia, R., & Mueller, G. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00110 · Cited by 116 · see citing works

Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study

Ljungqvist, J., Zetterberg, H., Mitsis, M., Blennow, K., & Skoglund, T. S. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4496 · Cited by 116 · see citing works

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Steinacker, P., Anderl-Straub, S., Diehl-Schmid, J., Semler, E., Uttner, I., von Arnim, C. A. F., Barthel, H., Danek, A., Fassbender, K., Fliessbach, K., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006318 · Cited by 116 · see citing works

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias

Abu‐Rumeileh, S., Capellari, S., Maserati, M. S., Polischi, B., Martinelli, P., Caroppo, P., Ladogana, A., & Parchi, P. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0331-1 · Cited by 114 · see citing works

A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia

Petzold, A., Keir, G., Warren, J. D., Fox, N. C., & Rossor, M. N. (2007) · Neurodegenerative Diseases · doi:10.1159/000101843 · Cited by 112 · see citing works

Serum neurofilament light chain in patients with acute cerebrovascular events

Marchis, G. M. D., Mira, K., Barro, C., Fladt, J. C., Traenka, C., Seiffge, D. J., Hert, L., Gensicke, H., Disanto, G., Sutter, R., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13554 · Cited by 112 · see citing works

Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease

Nguyen, H. P., Kobbe, P., Rahne, H., Wörpel, T., Jäger, B., Stephan, M., Pabst, R., Holzmann, C., Rieß, O., Korr, H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl394 · Cited by 111 · see citing works

Neurofilament light chain level is a weak risk factor for the development of MS

Arrambide, G., Espejo, C., Eixarch, H., Villar, L. M., Alvarez-Cermeño, J. C., Picón, C., Kühle, J., Disanto, G., Kappos, L., Sastre‐Garriga, J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003085 · Cited by 111 · see citing works

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease

Steinacker, P., Blennow, K., Halbgebauer, S., Shi, S., Ruf, V., Oeckl, P., Giese, A., Kühle, J., Slivarichova, D., Zetterberg, H., et al. (2016) · Scientific Reports · doi:10.1038/srep38737 · Cited by 111 · see citing works

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis

Novakova, L., Axelsson, M., Khademi, M., Zetterberg, H., Blennow, K., Malmeström, C., Piehl, F., Olsson, T. P., & Lycke, J. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516639384 · Cited by 110 · see citing works

Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations

Acosta‐Cabronero, J., & Nestor, P. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00266 · Cited by 109 · see citing works

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients

Hu, Y., Shanshu, H., Wang, X., Duan, Q., Khatoon, S., Iqbal, K., Grundke, I., & Wang, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00047-2 · Cited by 106 · see citing works

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

Oeckl, P., Jardel, C., Salachas, F., Lamari, F., Andersen, P. M., Bowser, R. P., de Carvalho, M. A., Costa, J., Damme, P. V., Gray, E., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1167913 · Cited by 103 · see citing works

CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis

Rossi, D., Volanti, P., Brambilla, L., Colletti, T., Spataro, R., & Bella, V. L. (2018) · Journal of Neurology · doi:10.1007/s00415-017-8730-6 · Cited by 101 · see citing works

Longitudinal diffusion tensor imaging in frontotemporal dementia

Mahoney, C. J., Simpson, I. J. A., Nicholas, J. M., Fletcher, P. D., Downey, L. E., Golden, H. L., Clark, C. N., Schmitz, N., Rohrer, J. D., Schott, J. M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24296 · Cited by 101 · see citing works

Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype

Abe, A., Numakura, C., Saito, K., Koide, H., Oka, N., Honma, A., Kishikawa, Y., & Hayasaka, K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.13 · Cited by 96 · see citing works

Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

Mellgren, Å., Price, R. W., Hagberg, L., Rosengren, L., Brew, B. J., & Gisslén, M. (2007) · Neurology · doi:10.1212/01.wnl.0000277635.05973.55 · Cited by 96 · see citing works

Plasma neurofilament light chain levels in Alzheimer’s disease

Zhou, W., Zhang, J., Ye, F., Xu, G., Su, H., Su, Y., & Zhang, X. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.027 · Cited by 95 · see citing works

Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net

Steinacker, P., Huss, A. M., Mayer, B., Grehl, T., Großkreutz, J., Borck, G., Kühle, J., Lulé, D. E., Meyer, T., Oeckl, P., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1241279 · Cited by 94 · see citing works

Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis

Grossman, M., Elman, L., McCluskey, L., McMillan, C. T., Boller, A., Powers, J., Rascovsky, K., Hu, W., Shaw, L., Irwin, D. J., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6064 · Cited by 94 · see citing works

Biomarkers in Neurodegenerative Diseases

Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92 · see citing works

Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

Jakobsson, J., Bjerke, M., Ekman, C. J., Sellgren, C. M., Johansson, A. G. M., Zetterberg, H., Blennow, K., & Landén, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.81 · Cited by 91 · see citing works

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes

Pijnenburg, Y. A. L., Verwey, N. A., van der Flier, W. M., Scheltens, P., & Teunissen, C. E. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.001 · Cited by 91 · see citing works

Biomarkers for neurodegenerative diseases

Henley, S. M. D., Bates, G. P., & Tabrizi, S. J. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000186842.51129.cb · Cited by 90 · see citing works

In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study

Petzold, A., Tisdall, M. M., Girbes, A. R. J., Martinian, L., Thom, M., Kitchen, N. D., & Smith, M. (2011) · Brain · doi:10.1093/brain/awq360 · Cited by 88 · see citing works

Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation

Pérez‐Ollé, R., Leung, C. L., & Liem, R. K. H. (2002) · Journal of Cell Science · doi:10.1242/jcs.00148 · Cited by 87 · see citing works

Assessing tissue damage in multiple sclerosis: a biomarker approach

Burman, J., Zetterberg, H., Fransson, M., Loskog, A., Raininko, R., & Fagius, J. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12239 · Cited by 86 · see citing works

Demyelination of superficial white matter in early Alzheimer's disease: a magnetization transfer imaging study

Fornari, E., Maeder, P. P., Meuli, R. A., Ghika, J. A., & Knyazeva, M. G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.014 · Cited by 86 · see citing works

Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models

Pérez‐Ollé, R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh236 · Cited by 85 · see citing works

Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes

Isgren, A., Sellgren, C. M., Ekman, C., Holmén‐Larsson, J., Blennow, K., Zetterberg, H., Jakobsson, J., & Landén, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.002 · Cited by 84 · see citing works

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression

Thompson, A. G. B., Luk, C. Y., Heslegrave, A., Zetterberg, H., Mead, S., Collinge, J., & Jackson, G. S. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317793 · Cited by 84 · see citing works

Biomarkers in spinal cord injury

Pouw, M. H., Hosman, A. J. F., van Middendorp, J. J., Verbeek, M. M., Vos, P. E., & van de Meent, H. (2009) · Spinal Cord · doi:10.1038/sc.2008.176 · Cited by 84 · see citing works

CSF –Neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage

Nylén, K., Csajbok, L. Z., Öst, M., Rashid, A., Karlsson, J.-E., Blennow, K., Nellgård, B., & Rosengren, L. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.029 · Cited by 83 · see citing works

CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls

Pijnenburg, Y. A. L., Janssen, J. C., Schoonenboom, N. S. M., Petzold, A., Mulder, C., Stigbrand, T. I., Norgren, N., Heijst, H., Hack, C. E., Scheltens, P., et al. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099473 · Cited by 82 · see citing works

Diagnostic Accuracy of Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis

Foerster, B. R., Dwamena, B. A., Petrou, M., Carlos, R. C., Callaghan, B. C., Churchill, C., Mohamed, M. A., Bartels, C., Benatar, M. G., Bonzano, L., et al. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.03.017 · Cited by 82 · see citing works

Overlapping molecular pathological themes link Charcot–Marie–Tooth neuropathies and hereditary spastic paraplegias

Timmerman, V., Clowes, V. E., & Reid, E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.010 · Cited by 81 · see citing works

Monoclonal Antibodies Selective for Low Molecular Weight Neurofilaments

Norgren, N., Karlsson, J.-E., Rosengren, L., & Stigbrand, T. (2002) · Hybridoma and Hybridomics · doi:10.1089/15368590252917647 · Cited by 81 · see citing works

Detection of Phosphorylated NF-H in the Cerebrospinal Fluid and Blood of Aneurysmal Subarachnoid Hemorrhage Patients

Lewis, S. B., Wolper, R. A., Miralia, L., Yang, C., & Shaw, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.12 · Cited by 80 · see citing works

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum

Wilke, C., Preische, O., Deuschle, C., Roeben, B., Apel, A., Barro, C., Maia, L., Maetzler, W., Kuhle, J., & Synofzik, M. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312972 · Cited by 79 · see citing works

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

Herbert, M. K., Aerts, M. B., Beenes, M., Norgren, N., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00091 · Cited by 77 · see citing works

Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study

Cai, L., & Huang, J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s173280 · Cited by 77 · see citing works

Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection

Traenka, C., Disanto, G., Seiffge, D. J., Gensicke, H., Hert, L., Grond‐Ginsbach, C., Peters, N., Regeniter, A., Kloß, M., Marchis, G. M. D., et al. (2015) · Cerebrovascular Diseases · doi:10.1159/000440774 · Cited by 70 · see citing works

Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis

Tortelli, R., Copetti, M., Ruggieri, M., Cortese, R., Capozzo, R., Leo, A., D’Errico, E., Mastrapasqua, M., Zoccolella, S., Pellegrini, F., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12421 · Cited by 67 · see citing works

Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury

Martínez‐Morillo, E., Childs, C., García, B. P., Menéndez, F. V. Á., Romaschin, A. D., Cervellin, G., Lippi, G., & Diamandis, E. P. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0908 · Cited by 67 · see citing works

Significance of CSF NfL and tau in ALS

Schreiber, S., Spotorno, N., Schreiber, F., Acosta‐Cabronero, J., Kaufmann, J., Machts, J., Dębska–Vielhaber, G., Garz, C., Bittner, D., Hensiek, N., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9043-0 · Cited by 67 · see citing works

Immunization With Neurofilament Light Protein Induces Spastic Paresis and Axonal Degeneration in Biozzi ABH Mice

Huizinga, R., Heijmans, N., Schubert, P., Gschmeissner, S., Hart, B. A. ‘., Herrmann, H. O., & Amor, S. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318040ad5c · Cited by 65 · see citing works

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice

Soylu-Kucharz, R., Sandelius, Å., Sjögren, M., Blennow, K., Wild, E. J., Zetterberg, H., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14179-1 · Cited by 63 · see citing works

Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?

Niemelä, V., Landtblom, A.-M., Blennow, K., & Sundblom, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172762 · Cited by 63 · see citing works

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease

Constantinescu, R., Romer, M., Oakes, D., Rosengren, L., & Kieburtz, K. D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.012 · Cited by 61 · see citing works

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

Lista, S., Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., dos Santos, A. M., Epelbaum, S., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.010 · Cited by 60 · see citing works

Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions

Sádaba, M. C., Tzartos, J. S., Paı́no, C. L., García-Villanueva, M., Alvarez-Cermeño, J. C., Villar, L. M., & Esiri, M. M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.020 · Cited by 59 · see citing works

Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis

Sako, W., Murakami, N., Izumi, Y., & Kaji, R. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.03.041 · Cited by 57 · see citing works

Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage

Zanier, E. R., Refai, D., Zipfel, G. J., Zoerle, T., Longhi, L. G., Esparza, T. J., Spinner, M. L., Bateman, R. J., Brody, D. L., & Stocchetti, N. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.177667 · Cited by 57 · see citing works

Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis

Villar, L. M., Picón, C., Costa‐Frossard, L., Alenda, R., García‐Caldentey, J., Espiño, M., Muriel, A., & Álvarez‐Cermeño, J. C. (2014) · European Journal of Neurology · doi:10.1111/ene.12579 · Cited by 56 · see citing works

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls

Rolstad, S., Jakobsson, J., Sellgren, C. M., Ekman, C. J., Blennow, K., Zetterberg, H., Pålsson, E., & Landén, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127100 · Cited by 52 · see citing works

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics

Magdalinou, N. K., Noyce, A. J., Pinto, R., Lindstrom, E., Holmén-Larsson, J., Holtta, M., Blennow, K., Morris, H. R., Skillbäck, T., Warner, T. T., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.016 · Cited by 49 · see citing works

Neuroimaging in the early diagnosis of neurodegenerative disease

Stoessl, A. J. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-5 · Cited by 48 · see citing works

Resistance is futile: antineuronal autoimmunity in multiple sclerosis.

Huizinga, R., Linington, C., & Amor, S. (2008) · Trends in immunology · doi:10.1016/j.it.2007.11.002 · Cited by 43 · see citing works

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders

Constantinescu, R., & Mondello, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2012.00187 · Cited by 41 · see citing works

Cerebrospinal fluid markers in MS patients and their healthy siblings

Haghighi, S., Andersen, O., Odén, A., & Rosengren, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00197.x · Cited by 39 · see citing works

Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

Mattsson, N., Rüetschi, U., Pijnenburg, Y., Blankenstein, M., Podust, V., Li, S., Fagerberg, I., Rosengren, L., Blennow, K., & Zetterberg, H. (2008) · Molecular Medicine Reports · doi:10.3892/mmr_00000025 · Cited by 34 · see citing works

Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis

Baldaranov, D., Khomenko, A., Kobor, I., Bogdahn, U., Gorges, M., Kassubek, J., & Müller, H. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00567 · Cited by 33 · see citing works

A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry

Zucchi, E., Lu, C., Cho, Y., Chang, R., Adiutori, R., Zubiri, I., Ceroni, M., Cereda, C., Pansarasa, O., Greensmith, L., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14542 · Cited by 32 · see citing works

Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis

Munemoto, M., Otaki, Y., Kasama, S., Nanami, M., Tokuyama, M., Yahiro, M., Hasuike, Y., Kuragano, T., Yoshikawa, H., Nonoguchi, H., et al. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.07.141 · Cited by 32 · see citing works

Multiple disease‐linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization

Goryunov, D., Nightingale, A., Bornfleth, L., Leung, C. L., & Liem, R. K. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05103.x · Cited by 29 · see citing works

Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease

Soussan, L., Tchernakov, K., Lavi, O., Yuvan, T., Wertman, E., & Michaelson, D. M. (1994) · Molecular Neurobiology · doi:10.1007/bf02816107 · Cited by 26 · see citing works

Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy

Petzold, A., Thompson, E. J., Keir, G., Quinn, N. P., Holmberg, B., Dizdar, N., Wenning, G. K., Rascol, O., TOLOSA, E. S., & Rosengren, L. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.037 · Cited by 24 · see citing works

Plasma neurofilament heavy chain levels in Huntington's disease

Wild, E. J., Petzold, A., Keir, G., & Tabrizi, S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.053 · Cited by 20 · see citing works

Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic

Niikado, M., Chrem-Méndez, P., Itzcovich, T., Kennedy, M. B., Calandri, I. L., Martinetto, H., Serra, M., Calvar, J., Campos, J., Russo, M. J., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly179 · Cited by 20 · see citing works

Creatine for Parkinson's disease

Xiao, Y., Luo, M., Luo, H., & Wang, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009646.pub2 · Cited by 18 · see citing works

Diffusion Tensor Imaging

Stieltjes, B., Brunner, R. M., Fritzsche, K. H., & Laun, F. B. (2013) · Springer eBooks · doi:10.1007/978-3-642-20456-2 · Cited by 18 · see citing works

CSF neurofilament light

Khalil, M., & Salzer, J. (2016) · Neurology · doi:10.1212/wnl.0000000000003107 · Cited by 17 · see citing works

Interpreting Magnetic Resonance Imaging Findings in Bipolar Disorder

Cousins, D. A., & Grunze, H. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00280.x · Cited by 16 · see citing works

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers

Rostgaard, N., Roos, P., Portelius, E., Blennow, K., Zetterberg, H., Simonsen, A. H., & Nielsen, J. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004799 · Cited by 13 · see citing works

Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models

Clement, A., Mitchelmore, C., Andersson, D. R., & Asuni, A. A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.030 · Cited by 10 · see citing works

[Neurofilament protein light in multiple sclerosis].

Zhang, Y., Li, X., & Qiao, J. (2007) · PubMed · Cited by 8 · see citing works

Antibodies to Neurofilaments

Talja, I., Reimand, T., Uibo, O., Reimand, K., Aun, S., Talvik, T., Janmey, P. A., & Uibo, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04624.x · Cited by 6 · see citing works

Creatine for Parkinson's disease

Wang, J., Xiao, Y., Chen, S., Cai, Z., Luo, M., & Luo, H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009646 · Cited by 5 · see citing works

[P2–338]: ARE NEUROFILAMENT LIGHT CHAIN AND WHITE MATTER INTEGRITY RELATED BIOMARKERS FOR FAMILIAL FRONTOTEMPORAL DEMENTIA?

Panman, J. L., van der Ende, E. L., Meeter, L. H. H., Bouts, M. J. R. J., Dopper, E. G. P., Jiskoot, L. C., Kaat, L. D., van Minkelen, R., Teunissen, C. E., Rombouts, S. A. R. B., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.992 · Cited by 1 · see citing works

The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease

Jung, Y., & Damoiseaux, J. S. (2023) · Brain · doi:10.1093/brain/awad267 · Cited by 117 · see citing works

Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update

Gouda, N., Elkamhawy, A., & Cho, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020371 · Cited by 94 · see citing works

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies

Mallick, R., Basak, S., Chowdhury, P., Bhowmik, P., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2025) · Pharmaceuticals · doi:10.3390/ph18010104 · Cited by 94 · see citing works

Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases

Park, Y., Nirajan, K. C., Paneque, A., & Cole, P. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126295 · Cited by 77 · see citing works

Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy

Ouédraogo, O., Rébillard, R., Jamann, H., Mamane, V. H., Clénet, M., Daigneault, A., Lahav, B., Uphaus, T., Steffen, F., Bittner, S., et al. (2020) · Epilepsia · doi:10.1111/epi.16742 · Cited by 64 · see citing works

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

Sampedro, F., Pérez‐González, R., Martínez‐Horta, S., Marín‐Lahoz, J., Pagonabarraga, J., & Kulisevsky, J. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.04.009 · Cited by 62 · see citing works

Blood-Based Biomarkers for Improved Characterization of Traumatic Brain Injury: Recommendations from the 2024 National Institute for Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative Blood-Based Biomarkers Working Group

Bazarian, J. J., Zetterberg, H., Buki, A., Dengler, B. A., Diaz-Arrastia, R., Korley, F. K., Lazarus, R., Meier, T. B., Mondello, S., Moritz, K., et al. (2025) · Journal of Neurotrauma · doi:10.1089/neu.2024.0581 · Cited by 61 · see citing works

The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review

Ramani, S., Berard, J. A., & Walker, L. A. S. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117229 · Cited by 57 · see citing works

Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders

Reddy, D. S., & Abeygunaratne, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911734 · Cited by 58 · see citing works

Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS

Brodovitch, A., Boucraut, J., Delmont, É., Parlanti, A., Grapperon, A., Attarian, S., & Verschueren, A. (2021) · Scientific Reports · doi:10.1038/s41598-020-80370-6 · Cited by 53 · see citing works

Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration

Shaw, G., Madorsky, I., Li, Y., Wang, Y.-S., Jorgensen, M., Rana, S. D., & Fuller, D. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcad067 · Cited by 46 · see citing works

Fluid Biomarkers for the Diagnosis of Neurodegenerative Diseases

Luebke, M., Parulekar, M., & Thomas, F. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100062 · Cited by 33 · see citing works

Biomarkers: Role and Scope in Neurological Disorders

Sharma, V., Singh, T. G., Mehta, V., & Mannan, A. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03873-4 · Cited by 39 · see citing works

CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways

Gheibihayat, S. M., Cabezas, R., Nikiforov, N. G., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2021) · Molecules · doi:10.3390/molecules26133943 · Cited by 34 · see citing works

Emerging Trends: Neurofilament Biomarkers in Precision Neurology

Sharma, P., Giri, A., & Tripathi, P. N. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04244-3 · Cited by 33 · see citing works

Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis

Hansra, G. K., Jayasena, T., Hosoki, S., Poljak, A., Lam, B. C. P., Rust, R., Sagare, A. P., Zloković, B. V., Thalamuthu, A., & Sachdev, P. S. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100216 · Cited by 31 · see citing works

Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease

Hsu, Y.-K., Chien, Y., Peng, S. S., Hwu, W., Lee, W., Lee, N., Huang, E. P.-Y., & Weng, W. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.10.005 · Cited by 31 · see citing works

Blood protein levels predict leading incident diseases and mortality in UK BiobankPreprint

Gadd, D. A., Hillary, R. F., Kuncheva, Z., Mangelis, T., Cheng, Y., Dissanayake, M., Admanit, R., Gagnon, J., Lin, T.-C., Ferber, K. L., et al. (2023) · medRxiv · doi:10.1101/2023.05.01.23288879 · Cited by 31 · see citing works

Prognostic value of serum/plasma neurofilament light chain for COVID ‐19‐associated mortality

Masvekar, R. R., Kosa, P. F., Jin, K., Dobbs, K., Stack, M., Castagnoli, R., Quaresima, V., Su, H. C., Imberti, L., Notarangelo, L. D., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51542 · Cited by 30 · see citing works

Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases

Liu, Z., & Song, S. (2025) · Genes · doi:10.3390/genes16020135 · Cited by 30 · see citing works

C-NODDI: A constrained NODDI model for axonal density and orientation determinations in cerebral white matter

Alsameen, M. H., Gong, Z., Qian, W., Kiely, M., Triebswetter, C., Bergeron, C. M., Cortina, L. E., Faulkner, M. E., Laporte, J. P., & Bouhrara, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1205426 · Cited by 29 · see citing works

Neurofilament light protein as a biomarker in depression and cognitive function

Travica, N., Berk, M., & Marx, W. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000756 · Cited by 28 · see citing works

A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies

Rübsamen, N., Willemse, E. A. J., Leppert, D., Wiendl, H., Nauck, M., Karch, A., Kuhle, J., & Berger, K. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.894119 · Cited by 27 · see citing works

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study

Simone, M., GIACOMO, A. D., Palumbi, R., Palazzo, C., Lucisano, G., Pompamea, F., Micella, S., Pascali, M., Gabellone, A., Marzulli, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033057 · Cited by 27 · see citing works

Neuroinflammatory Biomarkers Associated With Mild Traumatic Brain Injury History in Special Operations Forces Combat Soldiers

Powell, J. R., Boltz, A. J., DeCicco, J. P., Chandran, A. S., DeLellis, S. M., Healy, M. L., Kane, S. F., Lynch, J. H., Means, G. E., Hackney, A. C., et al. (2020) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000598 · Cited by 26 · see citing works

Biosensors, Recent Advances in Determination of BDNF and NfL

Mobed, A., Charsouei, S., Yazdani, Y., Gargari, M. K., Ahmadalipour, A., Sadremousavi, S. R., Farrahizadeh, M., Shahbazi, A., & Haghani, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01401-0 · Cited by 26 · see citing works

Neurofilament light chain levels correlate with clinical measures in CLN3 disease

Do, A. N. D., Sinaii, N., Masvekar, R. R., Baker, E. H., Thurm, A. E., Soldatos, A. G., Bianconi, S. E., Bielekova, B., & Porter, F. D. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-01035-3 · Cited by 24 · see citing works

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity

Masvekar, R. R., Phillips, J., Komori, M., Wu, T., & Bielekova, B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.649876 · Cited by 24 · see citing works

Neurofilament light protein as a biomarker in depression and cognitive function

Travica, N., Berk, M., & Marx, W. (2022) · Deakin Research Online (Deakin University) · Cited by 24 · see citing works

Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

Orhun, G., Esen, F., Yılmaz, V., Ulusoy, C. A., Şanlı, E., Yıldırım, E., Gurvit, H. I., Özcan, P. E., Sencer, S., Bebek, N., et al. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1916489 · Cited by 23 · see citing works

Comparing machine learning‐derived MRI‐based and blood‐based neurodegeneration biomarkers in predicting syndromal conversion in early AD

Cai, Y., Fan, X., Zhao, L., Liu, W., Luo, Y., Lau, A. Y. L., Au, L. W. C., Shi, L., Lam, B. Y. K., Ko, H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13083 · Cited by 23 · see citing works

Circular RNAs: novel diagnostic and therapeutic targets for ischemic stroke

Wang, Q., Liu, X., Zhao, J., & Zhu, R. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1826313 · Cited by 22 · see citing works

Precognition of mental health and neurogenerative disorders using AI-parsed text and sentiment analysis

Biró, A., Cuesta‐Vargas, A., & Szilágyi, L. S. (2023) · Acta Universitatis Sapientiae Informatica · doi:10.2478/ausi-2023-0022 · Cited by 22 · see citing works

Is blood pTau a reliable indicator of the CSF status? A narrative review

Antonioni, A., Raho, E. M., & Lorenzo, F. D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07258-x · Cited by 20 · see citing works

Plasma neurofilament light chain: A biomarker predicting severity in patients with acute ischemic stroke

Wu, J., Wu, D., Liang, Y., Zhang, Z., Zhuang, L., & Wang, Z. (2022) · Medicine · doi:10.1097/md.0000000000029692 · Cited by 19 · see citing works

Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal‐associated brain damage: A pilot study

Clergue‐Duval, V., Vrillon, A., Jeanblanc, J., Questel, F., Azuar, J., Fouquet, G., Mouton‐Liger, F., Rollet, D., Hispard, É., Bouaziz-Amar, É., et al. (2022) · Addiction Biology · doi:10.1111/adb.13232 · Cited by 18 · see citing works

White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels

Zimmermann, J., Friedli, N., Bavato, F., Stämpfli, P., Coray, R. C., Baumgartner, M. R., Grandgirard, D., Leib, S. L., Opitz, A., Seifritz, E., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103191 · Cited by 17 · see citing works

Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases

Liu, S., Huang, Z., Zhang, L., Pan, J., Lei, Q., Meng, Y., & Li, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00010 · Cited by 17 · see citing works

Charcot-Marie-Tooth disease: a review of clinical developments and its management - What’s new in 2025?

Grado, A. D., Serio, M., Saveri, P., Pisciotta, C., & Pareyson, D. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2470980 · Cited by 16 · see citing works

Investigating Associations Between Inflammatory Biomarkers, Gray Matter, Neurofilament Light and Cognitive Performance in Healthy Older Adults

Karoly, H. C., Skrzynski, C. J., Moe, E. N., Bryan, A. D., & Hutchison, K. E. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.719553 · Cited by 16 · see citing works

Perspectives in Amyotrophic Lateral Sclerosis: Biomarkers, Omics, and Gene Therapy Informing Disease and Treatment

Bono, N., Fruzzetti, F., Farinazzo, G., Candiani, G., & Marcuzzo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125671 · Cited by 15 · see citing works

Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics

Abiad, E. E., Al-Kuwari, A., Al-Aani, U., Jaidah, Y. A., & Châari, A. (2024) · Cells · doi:10.3390/cells13221901 · Cited by 16 · see citing works

Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques

Tavakoli, F., Khatami, S. S., Momeni, F., Azadbakht, J., & Ghasemi, F. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323666200901101955 · Cited by 15 · see citing works

Ultrasensitive SERS-LFA for the detection of neurofilament light chain and machine learning-assisted Alzheimer's disease classification

Sarathkumar, E., Menon, R. N., & Jayasree, R. S. (2025) · Nanoscale · doi:10.1039/d5nr03475b · Cited by 14 · see citing works

Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span

Elmers, J., Colzato, L. S., Akgün, K., Ziemssen, T., & Beste, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102037 · Cited by 14 · see citing works

Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease

Li, Q., Su, S., Feng, Y., Jia, M., Zhan, J., Liao, Z., Li, J., Li, X., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14056 · Cited by 13 · see citing works

Microarray Chip-Based High-Throughput Screening of Neurofilament Light Chain Self-Assembling Peptide for Noninvasive Monitoring of Alzheimer’s Disease

Zhou, Y., Cai, G., Wang, Y., Guo, Y., Yang, Z., Wang, A., Chen, Y.-S., Li, X., Chen, X., Hu, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c09642 · Cited by 12 · see citing works

Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment

Gaur, A., Gallagher, D., Herrmann, N., Chen, J. J., Marzolini, S., OH, P. I., Amemiya, Y., Seth, A. K., Kiss, A., & Lanctôt, K. L. (2024) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887241254469 · Cited by 11 · see citing works

Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Abdennadher, M., Inati, S. K., Soldatos, A. G., Norato, G., Baker, E. H., Thurm, A. E., Bartolini, L., Masvekar, R. R., Theodore, W. H., Bielekova, B., et al. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12366 · Cited by 11 · see citing works

Toward Precision Post-Stroke Rehabilitation Medicine: Integrating Molecular, Imaging, and Computational Biomarkers for Functional Outcome Prediction

Nartea, R., Săvulescu, S., Potcovaru, C.-G., & Poenaru, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228077 · Cited by 10 · see citing works

Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?

Custers, M., Vyver, M. V., Kaltenböck, L., Barbé, K., Bjerke, M., Eeckhaut, A. V., & Smolders, I. J. (2023) · Epilepsia · doi:10.1111/epi.17669 · Cited by 11 · see citing works

Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study

Balajková, V., Prokopcova, A., Elišák, M., Mojžišová, H., Pavelká, K., & Olejarová, M. (2025) · Lupus Science & Medicine · doi:10.1136/lupus-2024-001309 · Cited by 10 · see citing works

From Acute Injury to Chronic Neurodegeneration: Molecular Mechanisms Linking Secondary Brain Injury to Long-Term Pathology

Kaniuk, J. K., Kumar, D., Mazurek, C. Y., Khavari, S., Sollenberger, C. H., Ahuja, A., Mossner, J. M., & Ahuja, C. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157191 · Cited by 11 · see citing works

Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy

Zhang, Q., Fan, W., Sun, J., Zhang, J., & Yin, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s391325 · Cited by 10 · see citing works

Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?

Collins, J. M., Bindoff, A. D., Roccati, E., Alty, J., Vickers, J. C., & King, A. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1237284 · Cited by 10 · see citing works

Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project

Balayssac, D., Busserolles, J., Broto, C., Dalbos, C., Prival, L., Lamoine, S., Richard, D., Quintana, M., Herbet, A., Hilairet, S., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115535 · Cited by 10 · see citing works

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study

Colombo, E., Doretti, A., Rao, R., Verde, F., Sodano, M., Gobbi, A. D., di Cola, F. S., Ceccardi, G., Fiducia, B., Quaresima, V., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08011-2 · Cited by 9 · see citing works

Neurofilament light chain in Alzheimer’s disease

Fuloria, N. K., Sekar, M., Porwal, O., Ansari, M. T., Biswas, A., Narain, K., Biswas, S., Bhatia, S., Dhanalekshmi, U. M., & Fuloria, S. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120580 · Cited by 9 · see citing works

Effects of Aerobic Exercise on Markers of Brain Injury in Methamphetamine-Dependent Individuals: A Randomized Controlled Trial

Zhu, Z. A., Xu, J., Jin, Y., Wang, L., & Li, X. (2022) · Brain Sciences · doi:10.3390/brainsci12111521 · Cited by 9 · see citing works

Diagnostic and predictive power of plasma proteins in Alzheimer's disease: a cross-sectional and longitudinal study in China

Li, W., Sun, L., Yue, L., & Xiao, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-66195-7 · Cited by 9 · see citing works

Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer’s disease: insights from [18F]-florbetapir PET imaging

Chen, H., Zhang, M., Wei, M., Yu, X., Wang, Y., Yang, J., Li, R., Zhao, W., Wang, X., Zhang, S., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07172-8 · Cited by 9 · see citing works

Plasma neurofilament light chain as a biomarker in Wilson's disease

Yang, J., Huang, Z., Yang, H., Luo, Y., You, H., Chen, D., Pei, Z., & Li, X. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.12.003 · Cited by 9 · see citing works

Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome

Fang, X., Liang, Y., Zhang, W., Wang, Q., Chen, J., Chen, J., Lin, Y., Chen, Y., Yu, L., Wang, H., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02562-z · Cited by 8 · see citing works

A turn-on fluorescent immunosensor for neurodegenerative disease related neurofilament light chain protein

Song, Q., Zhang, H., Kong, J., Wong, M. S., & Li, H. (2025) · Microchimica Acta · doi:10.1007/s00604-025-06995-4 · Cited by 6 · see citing works

NREM sleep loss increases neurofilament light chain levels in APP/PS1 and C57BL/6 J mice

Liu, S., Zhang, Z., Shi, S., Meng, Y., Zhang, X., Lei, Q., & Li, Z. (2022) · Sleep And Breathing · doi:10.1007/s11325-022-02719-7 · Cited by 7 · see citing works

Blood‐based biomarkers for Alzheimer's disease

Chohan, P., Dashwood, M., Theodoulou, G., Reed, H., & Kuruvilla, T. (2022) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.764 · Cited by 7 · see citing works

White-matter abnormalities and cognitive dysfunction are linked to astrocyte activation in sickle mice

Hazra, R., Pu, H., Foley, L. M., LITTLE-IHRIG, L. L., Hitchens, T. K., Ghosh, S., Ofori-Acquah, S. F., Hu, X., & Novelli, E. M. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad149 · Cited by 5 · see citing works

Emerging blood biomarkers in Alzheimer’s disease: a proteomic perspective

Patel, N. K., Agrawal, N., Mishra, R., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Rana, M., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120397 · Cited by 6 · see citing works

Serum evaluation of NFL correlates with histological identification of degenerating axons

Fusco, A. F., Rana, S. D., Rayaprolu, S., MacIntyre, M. M., Jorgensen, M., Shaw, G., & Fuller, D. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115360 · Cited by 6 · see citing works

Sex and diet-dependent gene alterations in human and rat brains with a history of nicotine exposure

Vargas‐Medrano, J., Carcoba, L. M., Vidal-Martínez, G., Mulla, Z. D., Díaz, V., Ruiz-Velasco, A., Alvarez-Primo, F., Colina, G., Iñiguez, S. D., Thompson, P. M., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1104563 · Cited by 6 · see citing works

How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases

Saracino, D., & Ber, I. L. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.007 · Cited by 6 · see citing works

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

Kagerer, S. M., Awasthi, S., Ripke, S., Maceski, A. M., Benkert, P., Fall, A. B., Riederer, P. F., Fischer, P. A., Walitza, S., Grünblatt, E., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12504 · Cited by 6 · see citing works

Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia

Chong, J. S. X., Tan, Y. J., Koh, A. J., Ting, S. K. S., Kandiah, N., Ng, A. S. L., & Zhou, J. H. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231251 · Cited by 6 · see citing works

Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers

Ghafoor, D. D., Ahmad, D. O., Najmuldeen, H. H. R., Mohammed, S. J., Jalal, P. J., Mustafa, F. S., Alghofaili, F., Zangana, B. A., & Al-Bajalan, S. J. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02012-5 · Cited by 5 · see citing works

Subarachnoid hemorrhage: epidemiology, risk factors, pathogenesis, and clinical therapies

Shen, H., Yan, X., Zhao, M., Sun, J., & Huang, Y. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00455-y · Cited by 5 · see citing works

Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control

Elmers, J., Mückschel, M., Akgün, K., Ziemssen, T., & Beste, C. (2025) · Communications Biology · doi:10.1038/s42003-025-07974-4 · Cited by 5 · see citing works

Neurofilament light chain as a biomarker for neuronal injury in CNS infections

Hagberg, L., Zetterberg, H., & Gisslén, M. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2509023 · Cited by 5 · see citing works

Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms

Wang, H., Wang, W., Shi, H., Han, L., & Pan, P. (2020) · Medicine · doi:10.1097/md.0000000000021871 · Cited by 5 · see citing works

The clinical utility of neurofilament light chain for early detection and prediction of disease burden and severity in neuronopathic Gaucher disease

Svarny, L. M., Agha, A., Dao, J., Sandhu, B., Ivanova, M. M., & Göker-Alpan, Ö. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109181 · Cited by 4 · see citing works

Independent associations of phosphorylated tau181 and neurofilament light with cognitive outcomes in the Health and Aging Brain Study–Health Disparities (HABS-HD)

Housini, M., Contreras, J. A., Hayes, C. A., & The Health and Aging Brain Study (HABS‐HD) Study Team (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415367 · Cited by 4 · see citing works

Tick-borne encephalitis affects sleep–wake behavior and locomotion in infant rats

Chiffi, G., Grandgirard, D., Stöckli, S., Valente, L. G., Adamantidis, A., & Leib, S. L. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00859-7 · Cited by 4 · see citing works

Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis

Momeni, F., Ghaemmaghami, A. B., Nejati, M., Pourhanifeh, M. H., Sichani, L. S., Tamtaji, O. R., Momeni, M. R., Khosravi, A., Etemadifar, M., & Mirzaei, H. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191014162713 · Cited by 4 · see citing works

Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes

Richter, G., Kirsebom, B., Jarholm, J. A., Pålhaugen, L., Gísladóttir, B., Aarsland, D., Grøntvedt, G. R., Skogseth, R. E., Waterloo, K. K., Fladby, T., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.07.005 · Cited by 3 · see citing works

Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions

Russotto, A., Longobardi, A., Ciullini, A., Cazzaniga, F. A., Bacınoğlu, M. B., Borroni, B., Ghidoni, R., Moda, F., & Saraceno, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07471-6 · Cited by 3 · see citing works

Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 ( HSP ‐ SPG11 ) and Type 15 ( HSP ‐ ZFYVE26 )

Agianda, H. A. P., Alecu, J. E., Tam, A., Kim, H., Rong, J., Battaglia, N., Warren, K., Mannix, R., Setola, N., Barghigiani, M., et al. (2025) · Movement Disorders · doi:10.1002/mds.70142 · Cited by 3 · see citing works

Review on the neuron damage parameters in patients with end-stage renal disease

(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.07.045 · Cited by 3 · see citing works

A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain

Şişman, A. B., Bayar, M. D., İçöz, S., Yılmaz, V., Kürtüncü, M., Tüzün, E., Ertaş, M., & Baştan, B. (2020) · Case Reports in Neurology · doi:10.1159/000508944 · Cited by 3 · see citing works

Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38/MK2/NF-κB/CREB1/Nrf2/HO-1 signalling leading to Parkinson's disease

Nanda, A., Pandey, S. K., & Singh, R. K. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151150 · Cited by 2 · see citing works

Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS

López‐Blanch, R., Oriol‐Caballo, M., Estrela, J. M., & Obrador, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106727 · Cited by 2 · see citing works

ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study

Slattery, K., Kauss, M. C., Raval, D., Hsieh, E., Choi, A., Davis, T. S., Robins, K. R., Miller, H., Vera, E. M., Wright, M. L., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf002 · Cited by 2 · see citing works

Plasma biomarkers, brain amyloid pathology, and cortical thickness in a diverse middle-aged community cohort: the HCP-CoBRA studyPreprint

Brodman, S. T., Heaton, N., Triana‐Baltzer, G., Zeng, X., Gogola, A., Kamboh, M. I., Villemagne, V. L., López, O. L., Kolb, H. C., Deek, R. A., et al. (2025) · medRxiv · doi:10.1101/2025.07.10.25331312 · Cited by 2 · see citing works

Association between sleep duration and serum neurofilament light chain levels among adults in the United States

Liang, J., Ma, T.-C., Li, Y., Sun, R., Zhao, S., Shen, Y., Gao, H., Jing, Y., Bai, X., He, M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30699 · Cited by 1 · see citing works

AI-Assisted MRI

Zakharov, A. V., Колсанов, А. В., Khivintseva, E., Pavlova, O. N., Kalinin, V. А., Popov, N. V., & Karpova, N. E. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-9735-0.ch004 · Cited by 1 · see citing works

Insight into NeuroCOVID: neurofilament light chain (NfL) as a biomarker in post-COVID-19 patients with olfactory dysfunctions

Pennacchia, F., Zoccali, F., Petrella, C., Talarico, G., Rusi, E., Zingaropoli, M. A., Ruqa, W. A., Bruno, G., Capuano, R., Catini, A., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13222-w · Cited by 1 · see citing works

Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing–Remitting Multiple Sclerosis

Polunosika, E., Feldmane, M., Pastare, D., Simrén, J., Blennow, K., Zdanovskis, N., Zetterberg, H., Erts, R., & Karelis, G. (2025) · Neurology International · doi:10.3390/neurolint17080123 · Cited by 1 · see citing works

Neurodegeneration biomarkers in Alzheimer’s disease: axonal density index expands the “N” in the AT(N) framework

Flaherty, R., & Masurkar, A. V. (2026) · Journal of Clinical Investigation · doi:10.1172/jci202411 · Cited by 1 · see citing works

Blood-based biomarker analysis of Alzheimer’s disease by proteomics profiling

Velmurugan, G., Upadhyay, R., Sevanan, M., & Chinnathambi, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.03.003 · Cited by 1 · see citing works

Biomarkers of chemical- and drug-induced neurotoxicity: A review of mechanistic insights and neuroprotective strategies

Alshammari, A. A. A., & Mani, V. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116335 · Cited by 1 · see citing works

Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications

Rasmi, Y., Farnamian, Y., Boras, M. M., İnandıklıoğlu, N., Shirima, C. A., & Jalali, L. (2025) · Future Virology · doi:10.1080/17460794.2025.2480963 · Cited by 1 · see citing works

Uman Type NF-L Antibodies Are Effective Reagents for the Imaging of NeurodegenerationPreprint

Shaw, G., Madorsky, I., Li, Y., Wang, Y.-S., Rana, S. D., & Fuller, D. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.27.504533 · Cited by 1 · see citing works

Neurofilament light chain as a biomarker in neurological disorders

Gaetani, L., Blennow, K., Calabresi, P., Di Filippo, M., Parnetti, L., & Zetterberg, H. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320106 · Cited by 1,334 · see citing works

Role of Neurofilament Light Chain as A Biomarker in Neurological Disorders: A Literature Review

Abd-ElHady, M. E., Yassine, I., Hashish, E. A., Anani, M. M., & Negm, M. I. (2023) · SVOA Neurology · doi:10.58624/svoane.2023.04.099 · Cited by 1 · see citing works

Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 1 : Intérêt des neurofilaments dans la prise en charge des maladies neurodégénératives

Delaby, C., Bousiges, O., Bouvier, D., Fillée, C., Fourier, A., Mondésert, E., Nezry, N., Omar, S., Quadrio, I., Rucheton, B., et al. (2022) · Annales de biologie clinique · doi:10.1684/abc.2022.1757

Neurofilament Light Chain as a Biomarker in Neurology

Szyłak, E., Czarnowska, A., Kulczyńska‐Przybik, A., Kopitelow, J., Mroczko, B., Kochanowicz, J., & Kułakowska, A. (2026) · European Neurology · doi:10.1159/000552933 · Cited by 1 · see citing works

Neurofilament light chain (NfL) as a biomarker for neurodegeneration: Protein biology, detection methods, and clinical applications

Rajesh, N., Jasmine, R., Joji, R., Sivakumar, S., & Francis, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.009